Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210036181 210013567 1.64 87.6 Curative (C) 2015-11-27 2015-12-17 Cytarabine Intrathecal (any age) 02 N 210041470 PENTOSTATIN + RITUXIMAB
210036182 210028105 1.86 70.8 Palliative (P) 2015-09-06 2015-10-02 Abiraterone 2 N 210041630 CABAZITAXEL
210036183 210013623 1.62 49 Curative (C) 2019-11-30 2020-02-06 CARBOPLATIN + ETOPOSIDE + VINCRISTINE SULPHATE N N 210041817 UKALL2003
210036184 210022512 1.82 75.6 Palliative (P) 2016-09-29 2016-09-29 Dactinomycin + Vincristine 2 Y 210041854 NHL 2003
210036185 210013631 1.87 null null null 2016-09-27 Maintenance Therapy ALL 2 N 210041861 VINORELBINE
210036186 210022531 0 15.5 Curative (C) null 2017-03-30 DAUNORUBICIN + VINCRISTINE 02 N 210042069 DAUNORUBICIN
210036187 210013673 null 86.5 null null 2018-12-05 Maintenance Therapy ALL N null 210000284 MELPHALAN
210036188 210013710 1.67 6.25 Curative (C) 2018-09-24 2019-01-29 Cytarabine intrathecal N N 210021324 IVAC
210036189 210022576 1.84 18.1 Curative (C) 2017-11-06 2017-11-07 FCR IV - Cycle 2 onwards N N 210023716 HYDROXYCARBAMIDE
210036190 210013786 1.73 70.2 Adjuvant (A) 2017-12-13 2018-08-04 DAUNORUBICIN + VINCRISTINE 1 N 210028705 ABVD
210036191 210013798 null 78.5 Curative (C) 2018-08-24 2018-09-24 CARBO + ETOPOSIDE + VINCRISTINE 02 N 210029239 OFATUMUMAB
210036192 210013805 1.83 117.5 Curative (C) null 2016-11-19 Nilotinib N N 210029552 MYELOMA XI TRIAL
210036193 210013807 1.81 39.5 Disease modification (D) 2016-02-26 2016-07-23 PACLITAXEL 2 N 210029666 CYTARABINE HIGH DOSE
210036194 210013814 null 0 Curative (C) 2019-05-17 2019-06-24 Eribulin 02 null 210030225 VEDEX
210036195 210022628 1.82 63.8 Palliative (P) 2018-11-24 2019-08-14 CNS Medbl Std Risk Maint Cisplatin N N 210030551 CLARITY TRIAL
210036196 210013842 1.83 17.7 Palliative (P) 2017-10-14 2017-10-22 CYCLET 02 N 210031205 DAUNORUBICIN + VNCRISTINE
210036197 210031578 null null Curative (C) 2018-02-07 2018-11-04 Nilotinib N null 210031222 CAPECITABINE
210036198 210013882 0 59.2 Curative (C) 2017-11-07 2017-11-21 AML 19 TRIAL 2 N 210033322 PEMETREXED
210036199 210028225 0 78.9 Curative (C) 2020-03-31 2020-04-28 Cyclophos + Dex + Lenalidomide Y N 210034315 FLUDARABINE
210036200 210013931 1.6 88.6 Disease modification (D) 2018-09-26 2018-10-24 CLARITY Trial N N 210035201 IBRUTINIB + RITUXIMAB
210036201 210013941 1.67 52.3 Palliative (P) 2016-07-20 2016-07-26 CLL210 TRIAL Y N 210035533 IGEV R
210036202 210031600 1.57 25.5 Curative (C) 2018-02-14 2018-02-17 FLAG Y N 210036454 CLL210 TRIAL
210036203 210013979 1.72 103.4 Curative (C) 2019-03-21 2019-12-01 Capecitabine N null 210037672 LOMUSTINE + VINCRISTINE
210036204 210028255 1.7 77 null 2015-03-28 2015-04-04 Alemtuzumab + Cyclophos TBI Allo N N 210039506 CYTARABINE INTRATHECAL
210036205 210014016 1.53 74 Disease modification (D) 2018-03-28 2018-03-31 Packer Induction Vincristine + RT 02 Y 210040040 ABVD
210036206 210014048 null 64 Disease modification (D) 2020-02-12 2020-02-13 PENTOSTATIN + RITUXIMAB null null 210041755 ALL
210036207 210014051 null 19.3 Disease modification (D) 2019-04-23 2019-04-23 BOSUTINIB N null 210041781 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
210036208 210014081 null 66.3 Curative (C) 2018-06-15 2018-09-15 DACTINOMYCIN + CYCLO + VINCRISTINE 02 N 210034307 CYTARABINE INTRATHECAL
210036210 210004328 1.7 78 Adjuvant (A) null 2015-06-03 Temozolomide 200mg/m2 N N 210000208 TEMOZOLOMIDE
210036211 210004377 1.77 78 Palliative (P) 2017-10-31 2018-04-01 Temozolomide 200mg/m2 N null 210000395 TEMOZOLOMIDE
210036212 210004391 0 74.4 Adjuvant (A) 2017-06-18 2017-09-18 Temozolomide 200mg/m2 N Y 210000497 TEMOZOLOMIDE
210036213 210004402 1.65 68 Adjuvant (A) 2008-03-01 2014-06-11 Temozolomide 150mg/m2 N N 210000561 TEMOZOLOMIDE
210036214 210004406 null 72.2 Adjuvant (A) 2016-08-18 2016-12-17 Temozolomide 200mg/m2 2 N 210000602 TEMOZOLOMIDE
210036215 210038311 1.72 55.1 null 2016-11-30 2017-03-18 Temozolomide 200mg/m2 N N 210000612 TEMOZOLOMIDE
210036216 210004409 1.55 null Adjuvant (A) 2016-01-16 2016-04-08 TEMOZOLOMIDE 2 N 210000666 TEMOZOLOMIDE
210036217 210032436 null 119.8 Adjuvant (A) 2016-12-16 2017-03-04 Temozolomide 200mg/m2 N N 210000818 TEMOZOLOMIDE
210036218 210024739 null 52.9 Adjuvant (A) 2014-09-16 2014-09-22 TEMOZOLOMIDE N N 210001063 TEMOZOLOMIDE
210036219 210004511 1.58 91.2 Adjuvant (A) 2019-10-05 2020-01-19 Temozolomide 200mg/m2 N N 210001305 TEMOZOLOMIDE
210036220 210004530 1.71 67 Palliative (P) 2014-06-27 2014-10-28 Temozolomide 150mg/m2 N N 210001469 TEMOZOLOMIDE
210036221 210032466 1.8 70.95 Curative (C) 2015-12-21 2016-04-10 TEMOZOLOMIDE 02 N 210001570 TEMOZOLOMIDE
210036222 210004564 1.71 null Palliative (P) 2016-09-03 2016-09-04 TEMOZOLOMIDE 02 null 210001686 TEMOZOLOMIDE
210036225 210017381 null null Palliative (P) null 2014-06-01 TEMOZOLOMIDE N N 210002085 TEMOZOLOMIDE
210036226 210024814 null 87.9 Curative (C) 2014-03-04 2014-05-21 Temozolomide 200mg/m2 Y N 210002344 TEMOZOLOMIDE
210036227 210029539 1.83 null Curative (C) 2019-04-29 2019-08-06 Temozolomide 150mg/m2 N N 210002644 TEMOZOLOMIDE
210036228 210037774 1.68 50 Curative (C) 2017-05-27 2017-08-10 TEMOZOLOMIDE 02 null 210002681 TEMOZOLOMIDE
210036229 210004761 1.75 106.9 Adjuvant (A) 2015-01-30 2015-05-22 TEMOZOLOMIDE 2 N 210002776 TEMOZOLOMIDE
210036230 210035751 1.71 89.8 Curative (C) null 2015-12-17 Temozolomide 150mg/m2 N N 210002863 TEMOZOLOMIDE
210036231 210004797 1.72 62 Palliative (P) 2014-08-03 2014-11-02 Temozolomide 150mg/m2 N N 210002975 TEMOZOLOMIDE
210036232 210017477 1.61 82.3 Curative (C) 2017-10-24 2017-10-25 Temozolomide 200mg/m2 02 N 210003399 TEMOZOLOMIDE
210036233 210017493 1.81 84 Disease modification (D) 2018-04-24 2018-08-02 TEMOZOLOMIDE 02 N 210003544 TEMOZOLOMIDE